Dr. Clause Belka

Dr. Claus Belka emerges as a highly seasoned radiation oncologist, making significant contributions within the prestigious Ludwig-Maximilian University Hospital in Munich, Germany. As a leading figure in the field, Prof. Dr. Med. Claus Belka brings forth an impressive 27 years of experience, showcasing his expertise in delivering sophisticated services in radiation therapy. Dr. Belka is well-versed in a spectrum of advanced techniques, including image-guided radiation therapy, intensity-modulated radiation therapy, pulmonary stereotaxis, brain radiosurgery, catheter administration of radioactive drugs, and whole-body radiation. His academic journey, spanning from 1986 to 1993, led him to complete his studies in Human Medicine at the University of Essen. Additionally, he earned his Doctoral degree from the Faculty of Human Genetics at the same institution. Dr. Belka's vast expertise extends to the treatment of various cancers, encompassing breast cancer, lymphomas & leukemia, gynecological cancers, prostate cancer, urological malignancies, lung & mediastinal cancer, gastrointestinal tumors, brain & spinal cord tumors, bone & soft tissue sarcomas, skin tumors, head & neck tumors, and other benign diseases. His specialized treatments also include intraoperative radiotherapy, implantation of radioactive 125-iodine grains, and other therapeutic services. Recognized for his significant contributions to the field of radiation oncology, Dr. Claus Belka has received awards from various esteemed societies. Furthermore, his research prowess is evident through the publication of several scholarly articles, garnering substantial citations. Currently, he holds the esteemed position of Head of the Department at Ludwig Maximilian University Hospital in Munich, along with serving as the Associate Director in the Department of Radiation Oncology at Eberhard-Karls-University of Tuebingen. Dr. Belka's multifaceted career showcases not only his dedication to patient care but also his commitment to advancing the field of radiation oncology through research and leadership.